Publicações

Avelumab Expanded Access Program in Metastatic Merkel Cell Carcinoma: Efficacy and Safety Findings from Patients in Europe and the Middle East

AuthID
P-00V-ADV

Author(s)

Ascierto, PA

Orlova, K

Grignani, G

Dudzisz Sledz, M

Fenig, E

Sileni, VC

Fazio, N

Samimi, M

Mortier, L

Gebhardt, C

Kramkimel, N

Steven, N

Bechter, O

Arance, A

Benincasa, E

Kostkova, L

Costa, N

Lorigan, P

Tipo de Documento

Article in Press

Year published

2021

Publicado

in INTERNATIONAL JOURNAL OF CANCER, ISSN: 0020-7136

Volume: 149, Número: 11, Páginas: 1926-1934 (9)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1002/ijc.33746

Pubmed: 34310716

SCOPUS: 2-s2.0-85116458545

Wos: WOS:000680507100001

Source Identifiers

ISSN: 0020-7136

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Avelumab Expanded Access Program in Metastatic Merkel Cell Carcinoma: Efficacy and Safety Findings from Patients in Europe and the Middle East

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Avelumab Expanded Access Program in Metastatic Merkel Cell Carcinoma: Efficacy and Safety Findings from Patients in Europe and the Middle East

Links Úteis

Ajuda